<h1>Pharmaceutical company acquires majority stake in rival firm through Rs 19,500-crore deal creating India's second largest pharma entity</h1> A pharmaceutical company announced acquisition of majority stake in another pharmaceutical firm in a Rs 19,500-crore deal, making it India's second most valued pharma company. The acquirer will purchase 46.39% stake from promoters for Rs 11,917 crore at Rs 1,600 per share, plus 2.80% from employees. An additional 26% open offer will be made at Rs 1,639.18 per share. Post-acquisition, the target company will merge with the acquirer, with shareholders receiving 51 shares for every 100 held. This represents the second-largest pharma sector deal after a 2015 transaction, subject to regulatory approvals.